Comparison Overview

Biotron Laboratories, Inc. (now Actylis)

VS

AkzoNobel

Biotron Laboratories, Inc. (now Actylis)

750 North 120 West, Centerville, 84014, US
Last Update: 2026-04-03
Between 750 and 799

Actylis was created from the merger of eight experienced specialty manufacturing companies and three sourcing firms, integrated into a single entity. Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and AgriScience industries. Actylis' Nutrition division specializes in manufacturing mineral amino acid chelates and complexes. Our goal is to provide our corporate customers top-tier service and continual product improvement resulting in premium materials. To accomplish these goals, we rely on a depth of experience, a rigorous approach to product quality and emphasize both scientific validation and integrity.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 18
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

AkzoNobel

Christian Neefestraat 2, Amsterdam, Noord Holland, NL, 1077 WW
Last Update: 2026-04-01
Between 0 and 549

Since 1792, we’ve been supplying the innovative paints and coatings that help to color people’s lives and protect what matters most. Our world class portfolio of brands – including Dulux, International, Sikkens and Interpon – is trusted by customers around the globe. We’re active in more than 150 countries and use our expertise to sustain and enhance everyday life. Because we believe every surface is an opportunity. It’s what you’d expect from a pioneering and long-established paints company that’s dedicated to providing sustainable solutions and preserving the best of what we have today – while creating an even better tomorrow. Let’s paint the future together.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 31,151
Subsidiaries: 10
12-month incidents
2
Known data breaches
0
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/akzonobel.jpeg
AkzoNobel
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Biotron Laboratories, Inc. (now Actylis)
100%
Compliance Rate
0/4 Standards Verified
AkzoNobel
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for Biotron Laboratories, Inc. (now Actylis) in 2026.

Incidents vs Chemical Manufacturing Industry Average (This Year)

AkzoNobel has 25.09% fewer incidents than the average of same-industry companies with at least one recorded incident.

Incident History — Biotron Laboratories, Inc. (now Actylis) (X = Date, Y = Severity)

Biotron Laboratories, Inc. (now Actylis) cyber incidents detection timeline including parent company and subsidiaries

Incident History — AkzoNobel (X = Date, Y = Severity)

AkzoNobel cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
Incidents

No Incident

https://images.rankiteo.com/companyimages/akzonobel.jpeg
AkzoNobel
Incidents

Date Detected: 3/2026
Type:Ransomware
Motivation: Financial gain, Operational disruption, Data theft
Blog: Blog

Date Detected: 2/2026
Type:Ransomware
Attack Vector: Exploitation of unpatched vulnerability (React2Shell)
Motivation: Data exfiltration and ransom demand
Blog: Blog

Date Detected: 12/2024
Type:Ransomware
Motivation: Financial gain (ransom demand), data exfiltration
Blog: Blog

FAQ

Biotron Laboratories, Inc. (now Actylis) company demonstrates a stronger AI Cybersecurity Score compared to AkzoNobel company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

AkzoNobel company has historically faced a number of disclosed cyber incidents, whereas Biotron Laboratories, Inc. (now Actylis) company has not reported any.

In the current year, AkzoNobel company has reported more cyber incidents than Biotron Laboratories, Inc. (now Actylis) company.

AkzoNobel company has confirmed experiencing a ransomware attack, while Biotron Laboratories, Inc. (now Actylis) company has not reported such incidents publicly.

Neither AkzoNobel company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing a data breach publicly.

Neither AkzoNobel company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing targeted cyberattacks publicly.

Neither Biotron Laboratories, Inc. (now Actylis) company nor AkzoNobel company has reported experiencing or disclosing vulnerabilities publicly.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds any compliance certifications.

Neither company holds any compliance certifications.

AkzoNobel company has more subsidiaries worldwide compared to Biotron Laboratories, Inc. (now Actylis) company.

AkzoNobel company employs more people globally than Biotron Laboratories, Inc. (now Actylis) company, reflecting its scale as a Chemical Manufacturing.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds SOC 2 Type 1 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds SOC 2 Type 2 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds ISO 27001 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds PCI DSS certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds HIPAA certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor AkzoNobel holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.